We're sorry, but your current browser configuration is not compatible with this site. Please enable JavaScript or switch to a JavaScript-capable browser. Learn how to enable JavaScript

Pharmacology & Medications

featured

Isoxazolines for Treatment of Demodicosis

Generalized demodicosis can be difficult to treat. Examine this review of the extra-label use of isoxazolines for treatment of this problematic condition.

Most Popular

Pharmacology & Medications

Top 5 Trilostane Monitoring Tips

Peer Reviewed

Antimicrobial Resistance in Canine Urinary Tract Infections

Extended Use of Open Liposomal Bupivacaine Vials

Amoxicillin/Clavulanic Acid in Cats with & without Chronic Kidney Disease

Capsules

Pharmacology & Medications

Research Note: Oxyclozanide as Treatment for Small Animal Bacterial Pathogens

Research Note: Antibody Response to Feline Panleukopenia Virus Vaccination

Research Note: Effect of Prolonged Famotidine Administration in Cats

Research Note: Pharmacokinetics of Gabapentin in Cats

Research Note: Concurrent Administration & Pharmacokinetics of Extended- Release Levetiracetam

Research Note: Akkermansia muciniphila After Antimicrobial Administration

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

It's Free & Simple

Delivered to Your Inbox

Join the Conversation

Facebook

Twitter

Home

Global Edition

About Us

Employment

Capsules

Advertise

Create Account

Brief Media

INDUSTRY NEWS

Pharmacology & Medications

Isoxazolines for Treatment of Demodicosis

Generalized demodicosis can be difficult to treat. Examine this review of the extra-label use of isoxazolines for treatment of this problematic condition.

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

Subscribe

Newsletter

Facebook

Twitter